Grail (GRAL) Total Current Liabilities (2023 - 2026)
Grail's (GRAL) quarterly Total Current Liabilities came in at $83.5 million in Q2 2026, up 18.27% on a YoY basis from $70.6 million in Q2 2025, and up 11.82% quarter-over-quarter from $74.7 million in Q1 2026.
Analysis
Grail (GRAL) Total Current Liabilities (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Total Current Liabilities for 4 consecutive years, with $83.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 18.27% year-over-year to $83.5 million; the trailing twelve-month figure through Jun 2026 stood at $83.5 million (up 18.27% YoY), and the FY2025 full-year result was $79.7 million, up 3.57% from the prior year.
- Total Current Liabilities advanced to $83.5 million in Q2 2026 per GRAL's latest filing, from $74.7 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $163.6 million in Q4 2023 and bottomed at $70.6 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $88.4 million across 4 years, with a median of $78.6 million in 2025.
- The sharpest annual moves came in 2024 and 2026: Total Current Liabilities sank 52.98% in 2024, then increased 18.27% in 2026.
- Over 4 years, Total Current Liabilities stood at $163.6 million in 2023, then tumbled by 52.98% to $76.9 million in 2024, then advanced by 3.57% to $79.7 million in 2025, then climbed by 4.86% to $83.5 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $83.5 million, $74.7 million, and $79.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 553.20 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 1.79 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 2.12 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 338.96 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 391.49 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 191.44 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 231.24 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 55.73 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 87.71 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 83.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.54 Mn |
| Mar 31, 2026 | 74.71 Mn |
| Dec 31, 2025 | 79.67 Mn |
| Sep 30, 2025 | 77.43 Mn |
| Jun 30, 2025 | 70.64 Mn |
| Mar 31, 2025 | 74.98 Mn |
| Dec 31, 2024 | 76.93 Mn |
| Sep 30, 2024 | 94.27 Mn |
| Jun 30, 2024 | 88.18 Mn |
| Dec 31, 2023 | 163.61 Mn |